L Antonuzzo

机构：Azienda Ospedaliero-Universitaria Careggi, University of Florence

发表论文 19 篇 · 总被引 8 次 · h-index 2

代表论文

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations (2026 · New England Journal of Medicine · 被引 5)
Sunvozertinib monotherapy versus platinum-based chemotherapy as first-line treatment for advanced NSCLC with EGFR exon20ins: Primary analysis of a multinational phase 3 randomized study (WU-KONG28). (2026 · Journal of Clinical Oncology · 被引 2)
A phase 1/2 study of the next-generation nectin-4–targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic cervical cancer. (2026 · Journal of Clinical Oncology · 被引 1)
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study (2026 · Frontiers in Immunology)
From trials to the clinic: Real-world experience with mirvetuximab soravtansine in platinum-resistant ovarian cancer and the "Lazarus effect. (2026 · Journal of Clinical Oncology)
A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA–positive colorectal cancer. (2026 · Journal of Clinical Oncology)